中国平安
02318 · HK
02318 Research Preview
| Metric | Reading |
|---|---|
| Price | HKD 53.85 |
| Daily move | -4.01% |
| Strategy score | 50/100 (Hold) |
| Trend | Consolidation |
| RSI | N/A |
| MACD | N/A |
| Support (estimated) | N/A |
| Resistance (estimated) | N/A |
| 30-session range position | N/A |
| Data confidence | Low (technical), Medium (fundamental) |
The technical confidence flag is Low because every indicator field in the supplied dataset is unavailable; the only observable price reference points are the session high/low (55.95 / 53.15).
| Indicator | Reading | State |
|---|---|---|
| MA5 / MA10 / MA20 / MA60 | N/A | Insufficient moving-average data |
| RSI14 / RSI6 | N/A | RSI14 unavailable |
| MACD line / signal / histogram | N/A | MACD unavailable |
| KDJ K / D / J | N/A | KDJ unavailable |
| Bollinger upper / middle / lower | N/A | Bollinger position unavailable |
| ATR14 / ATR14% | N/A | ATR unavailable |
| OBV / OBV 20-session slope | N/A | OBV unavailable |
| CCI20 | N/A | CCI unavailable |
What is confirmed: nothing on the technical side can be confirmed from the supplied dataset. Every momentum, trend, volatility, and volume indicator is unavailable.
What is conflicted: no conflict can be assessed, because there are no populated indicator pairs to compare (for example, no MA cross to validate against MACD, and no RSI to cross-check against KDJ).
What is missing: the entire technical panel. Moving-average structure, RSI, MACD, KDJ, Bollinger position, ATR, OBV, and CCI are all absent, as are the estimated support/resistance levels and the 30-session range position. The five strategy sub-scores (MA交叉, MACD背离, RSI极值, 布林带, 量价关系) each return 50/100 Hold with the explicit reason 数据不足 (insufficient data), so the headline 50/100 score reflects a neutral default, not a measured neutral reading. No custom indicators were supplied.
| Axis | Reading | Source | Confidence |
|---|---|---|---|
| PE | 7.23 | AkShare Eastmoney HK financial indicators | Medium |
| PB | 0.97 | AkShare Eastmoney HK financial indicators | Medium |
| PEG proxy | 1.08 | StockKit scenario model | Medium |
| StockKit fair value range | Bear HKD 100.75 / Base HKD 130.1 / Bull HKD 166.35 | StockKit DCF scenario model | Medium |
| Base fair-value gap | +141.6% | StockKit DCF scenario model | Medium |
| 5Y growth forecast | Bear +0.68% / Base +6.68% / Bull +12.68% | StockKit scenario model | Medium |
| Operating income | HKD 1.14T | AkShare Eastmoney HK financial indicators | Medium |
| Holder profit | HKD 134.78B | AkShare Eastmoney HK financial indicators | Medium |
| EPS TTM | 7.44 | AkShare Eastmoney HK financial indicators | Medium |
| Book value per share | 55.25 | AkShare Eastmoney HK financial indicators | Medium |
| Net margin | +13.88% | AkShare Eastmoney HK financial indicators | Medium |
The PEG proxy (1.08), fair-value range, base fair-value gap, and 5Y growth forecast are StockKit scenario-model outputs computed from public financial history; they are internally computed forecasts, not analyst consensus targets. The reported period used for the AkShare fundamentals is 2025-12-31. Observations from the supplied figures: PE of 7.23 and PB of 0.97 (below book) are the populated anchors, and book value per share of 55.25 sits close to the current HKD 53.85 price, consistent with the sub-1.0 PB reading. Gross margin, EV/EBITDA, market cap, dividend yield, and the 52-week range were not supplied and are therefore omitted. The +141.6% base gap is a large divergence between model output and spot price and should be treated as a model reading carrying medium confidence, not a price prediction.
| Date | Headline | Source | Status |
|---|---|---|---|
| 2026-06-17 | FloPatch Named Leading Innovation in Sepsis Management at 2026 Unite for Sepsis Symposium | Financial Post | Confirmed (relevance unclear) |
| 2026-06-09 | NEXT: What If You Could Get The Benefits Of Sleep Without Actually Sleeping? | Studyfinds.com | Confirmed (relevance unclear) |
Why each matters: neither supplied headline references 中国平安, insurance, financial services, or the HK listing, so their direct relevance to 02318 is not established by the dataset. The FloPatch sepsis-management item and the sleep-science item read as general or unrelated coverage that surfaced in the headline feed. On the available data, neither functions as a company-specific catalyst.
Missing data: no confirmed company-specific catalysts are present. Earnings dates, dividend announcements, regulatory filings, and corporate-action items are not in the supplied dataset, so the catalyst timeline cannot be populated with 02318-specific events. This section carries low confidence on catalyst relevance.
| Source | Status | Reading | Confidence |
|---|---|---|---|
| NewsAPI headline coverage | 2 headlines | Financial Post x1, Studyfinds.com x1 | Low |
| Social sentiment | Not connected | No social sentiment conclusion is drawn | Low |
No provider-level sentiment score was supplied for this symbol. Social sentiment is marked Not connected, so no Reddit, X, StockTwits, or local-forum reading is drawn. The only sentiment-adjacent signal is the two-headline news count, which is too thin and too loosely related to the company to support a directional sentiment view. Overall sentiment confidence is Low.
| Scenario | Trigger condition | What would confirm it | What would invalidate it |
|---|---|---|---|
| Base | Price holds within the observed intraday band around HKD 53.15-55.95; strategy stays at 50/100 consolidation | Restored technical data showing a flat MA structure and neutral RSI/MACD alongside stable PE near 7.23 | A decisive break and close outside the intraday band on expanding volume once data is restored |
| Upside | Price reclaims and holds above the session high of HKD 55.95; valuation gap toward StockKit base HKD 130.1 begins to narrow via re-rating | RSI/MACD turning constructive (once available) and confirming follow-through volume above the unconfirmed 20-session average | Failure to hold above 55.95, or fundamentals deteriorating below the supplied PE 7.23 / PB 0.97 anchors |
| Downside | Price loses the session low of HKD 53.15 after the -4.01% move | Continued lower closes with volume above the (currently unavailable) 20-session average, and PB falling further below 0.97 | Reclaiming HKD 53.15 and stabilizing within the intraday band |
All scenario triggers lean on the intraday 53.15 / 55.95 levels and the StockKit valuation anchors because estimated support/resistance, the 30-session range, and the full technical panel are unavailable. These are watch levels for observation, not instructions.
| Risk | Evidence | Trigger | Monitoring action |
|---|---|---|---|
| Data-completeness risk | All technical indicators (MA/RSI/MACD/KDJ/Bollinger/ATR/OBV/CCI) return N/A; all five strategy sub-scores cite 数据不足 | Indicators remain unavailable on the next refresh | Re-pull the technical feed before acting on any level |
| Single-session drawdown risk | Daily move of -4.01% with price (53.85) near the session low of 53.15 | Close below 53.15 | Track whether the low holds on the following sessions |
| Valuation-model divergence risk | StockKit base fair value HKD 130.1 implies a +141.6% gap to spot; this is model output, not consensus | Gap persists with no fundamental change in PE 7.23 / PB 0.97 | Treat the gap as a medium-confidence model reading, not a target; watch fundamentals at next report |
| Catalyst-relevance risk | Both supplied headlines (FloPatch sepsis; sleep science) lack a clear link to 02318 | No 02318-specific news surfaces | Wait for company-specific, attributable headlines before drawing news conclusions |
| Sentiment-blind-spot risk | Social sentiment Not connected; no provider sentiment score | Continued absence of a sentiment feed | Do not infer crowd positioning until a connected source is available |
数据不足
数据不足
数据不足
数据不足
数据不足
FloPatch Named Leading Innovation in Sepsis Management at 2026 Unite for Sepsis Symposium
Financial Post · 2026-06-17
NEXT: What If You Could Get The Benefits Of Sleep Without Actually Sleeping?
Studyfinds.com · 2026-06-09
Research boundary
StockKit organizes market data and model output for research workflows. It does not provide personalized advice or trade instructions. Verify important information with primary sources before any investment decision.